Firefly Neuroscience

Firefly Neuroscience

Health Care Technology
Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.

$14.7M

Market Cap • 11/13/2026

2022

(4 years)

Founded

2024

(2 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

1,1

P/S

7,2

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

0,9

EPS

—

Market Cap

Market Cap

14,7M

EV

6,7M

EV/Revenue

3,3

EV/EBITDA

-0,9

EV/EBIT

-0,8

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-54,3%

Total Yield

-54,3%

Payout

0%

Retained Earnings

-117M

Profitability

Gross Margin

57,4%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

86,9%

Capex/Revenue

9,5%

Capex/D&A

101%

Capex/OCF

-2,9%

SBC/OCF

—

% PPE

1,9%

% Goodwill

33,5%

ROE

—

ROIC

—

Growth

CAGR OCF 5Y

176,4%

Leverage

N.D./EBITDA

1

Debt/Equity

0%

Current Ratio

4,5

Quick Ratio

4,1

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium